ESLT Stock Analysis: Elbit Systems | NASDAQ
Aerospace & Defense | NASDAQ, USA | Market Cap: 37.632m USD | 12M Return: 67.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 76.4M
EPS Trend: 97.8%
Qual. Beats: 9
Rev. Trend: 99.5%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Elbit Systems Ltd. (NASDAQ: ESLT) is an Israeli defense and homeland security company that develops and supplies products and services across five segments: Aerospace; C4I and Cyber; ISTAR and Electronic Warfare; Land; and Elbit Systems of America. Its offerings span airborne platforms, unmanned aerial systems, precision-guided munition sensors, command and control systems, electro-optic and laser solutions, naval combat management, electronic warfare and radar systems, and land weapons including turrets and active protection systems.
The company sells to governments and commercial customers worldwide, with a notable presence in Israel, North America, and Europe. It was incorporated in 1966 and is headquartered in Haifa, Israel, and has been listed on NASDAQ since its 1996 IPO.
Elbit operates in the global defense electronics industry, which is characterized by multi-year government contracts, high barriers to entry due to security clearances and technical complexity, and demand driven by national defense budgets and geopolitical tensions. As an Israeli prime contractor, it exports a significant share of its output, making it one of the larger publicly traded defense electronics firms outside the United States.
- Israeli defense budget expands amid Gaza war and regional tensions
- Elbit Systems of America secures new US military aviation contracts
- Unmanned aerial systems and EW demand drives ISTAR segment growth
| Net Income: 588.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.36 > 1.0 |
| NWC/Revenue: 29.14% < 20% (prev 16.26%; Δ 12.88% < -1%) |
| CFO/TA 0.07 > 3% & CFO 892.4m > Net Income 588.0m |
| Net Debt (532.9m) to EBITDA (861.1m): 0.62 < 3 |
| Current Ratio: 1.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (48.1m) vs 12m ago 5.66% < -2% |
| Gross Margin: 24.70% > 18% (prev 24.02%; Δ 0.68% > 0.5%) |
| Asset Turnover: 66.96% > 50% (prev 63.14%; Δ 3.82% > 0%) |
| Interest Coverage Ratio: 5.15 > 6 (EBIT TTM 685.7m / Interest Expense TTM 133.1m) |
| A: 0.18 (Total Current Assets 8.31b - Total Current Liabilities 5.91b) / Total Assets 13.2b |
| B: 0.24 (Retained Earnings 3.15b / Total Assets 13.2b) |
| C: 0.06 (EBIT TTM 685.7m / Avg Total Assets 12.3b) |
| D: 0.47 (Book Value of Equity 4.26b / Total Liabilities 8.97b) |
| Altman-Z'' = 2.84 = A |
| DSRI: 1.04 (Receivables 4.14b/3.48b, Revenue 8.23b/7.17b) |
| GMI: 0.97 (GM 24.02% / 24.70%) |
| AQI: 0.94 (AQ_t 0.23 / AQ_t-1 0.24) |
| SGI: 1.15 (Revenue 8.23b / 7.17b) |
| TATA: -0.02 (NI 588.0m - CFO 892.4m) / TA 13.2b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of July 10, 2026, the stock is trading at USD 760.89 with a total of 53,777 shares traded. Over the past week, the price has changed by +0.12%, over one month by -9.04%, over three months by -17.85% and over the past year by +67.85%.
Current recommended Stop Loss: 711.90 (which is 6.4% or 1.6 ATR below the current price).
Elbit Systems has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold ESLT.
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 868.5 | 14.1% |
P/E Trailing = 64.9361
P/E Forward = 9.6618
P/S = 4.5716
P/B = 8.823
P/EG = 8.7866
Revenue TTM = 8.23b USD
EBIT TTM = 685.7m USD
EBITDA TTM = 861.1m USD
Long Term Debt = 248.3m USD (from longTermDebt, last quarter)
Short Term Debt = 179.3m USD (from shortTermDebt, last quarter)
Debt = 1.46b USD (from shortLongTermDebtTotal, last quarter) + Leases 563.0m
Net Debt = 532.9m USD (calculated: Debt 1.46b - CCE 925.3m)
Enterprise Value = 38.2b USD (37.6b + Debt 1.46b - CCE 925.3m)
Interest Coverage Ratio = 5.15 (Ebit TTM 685.7m / Interest Expense TTM 133.1m)
EV/FCF = 62.26x (Enterprise Value 38.2b / FCF TTM 613.0m)
FCF Yield = 1.61% (FCF TTM 613.0m / Enterprise Value 38.2b)
FCF Margin = 7.45% (FCF TTM 613.0m / Revenue TTM 8.23b)
Net Margin = 7.14% (Net Income TTM 588.0m / Revenue TTM 8.23b)
Gross Margin = 24.70% ((Revenue TTM 8.23b - Cost of Revenue TTM 6.20b) / Revenue TTM)
Gross Margin QoQ = 25.22% (prev 24.66%)
Tobins Q-Ratio = 2.88 (Enterprise Value 38.2b / Total Assets 13.2b)
Interest Expense / Debt = 9.12% (Interest Expense 133.1m / Debt 1.46b)
Taxrate = 9.56% (62.2m / 651.3m)
NOPAT = 620.2m (EBIT 685.7m * (1 - 9.56%))
Current Ratio = 1.41 (Total Current Assets 8.31b / Total Current Liabilities 5.91b)
Debt / Equity = 0.34 (Debt 1.46b / totalStockholderEquity, last quarter 4.26b)
Debt / EBITDA = 0.62 (Net Debt 532.9m / EBITDA 861.1m)
Debt / FCF = 0.87 (Net Debt 532.9m / FCF TTM 613.0m)
Total Stockholder Equity = 4.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.78% (Net Income 588.0m / Total Assets 13.2b)
RoE = 14.40% (Net Income TTM 588.0m / Total Stockholder Equity 4.08b)
RoCE = 15.83% (EBIT 685.7m / Capital Employed (Equity 4.08b + L.T.Debt 248.3m))
RoIC = 8.74% (NOPAT 620.2m / Invested Capital 7.09b)
WACC = 5.76% (E(37.6b)/V(39.1b) * Re(5.66%) + D(1.46b)/V(39.1b) * Rd(9.12%) * (1-Tc(0.10)))
Discount Rate = 5.66% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 77.78 | Cagr: 3.41%
[DCF] Terminal Value 76.45% ; FCFF base≈594.6m ; Y1≈637.2m ; Y5≈769.1m
[DCF] Fair Price = 240.6 (EV 11.8b - Net Debt 532.9m = Equity 11.3b / Shares 46.8m; r=8.35% [WACC [floored]]; 5y FCF grow 8.14% → 2.50% )
EPS Correlation: 97.79 | EPS CAGR: 31.52% | SUE: 2.95 | # QB: 9
Revenue Correlation: 99.46 | Revenue CAGR: 15.04% | SUE: 0.07 | # QB: 0
EPS current Quarter (2026-06-30): EPS=3.68 | Chg30d=+3.61% | Revisions=+50% | Analysts=4
EPS next Quarter (2026-09-30): EPS=3.83 | Chg30d=+3.25% | Revisions=+50% | Analysts=4
EPS current Year (2026-12-31): EPS=15.59 | Chg30d=+3.39% | Revisions=+50% | GrowthEPS=+22.2% | GrowthRev=+14.3%
EPS next Year (2027-12-31): EPS=18.06 | Chg30d=+4.25% | Revisions=+50% | GrowthEPS=+15.9% | GrowthRev=+12.9%
[Analyst] Revisions Ratio: +80% (up=12, down=0)